Leaders: Paul Studenic (Austria), Mary Canavan (Ireland)
Members: Giulio Cavalli (Italy), Diederik De Cock (Belgium, UK), Megan Hanlon (Ireland), Santiago Andrés Rodrigues Manica (Portugal), Ana Ortiz (Belgium, Portugal), Ivan Padjen (Croatia), Simone Parisi (Italy), Andrea Regel (Germany), Karen Schreiber (Denmark, UK), Simon Stones (UK), Sarah Wade (Ireland), Polona Zigon (Slovenia)
The EMEUNET website launched in June 2012 and since that time has had increasing traffic to the site with an average of 6.000 monthly visitors from around the world. We first joined social media by launching the EMEUNET Facebook page in February 2014, a Twitter feed in September 2014 and LinkedIn In October 2016 to ensure close contact with our members. Our YouTube channel offers a variety of short video clips, introducing EMEUNET, research opportunities and researchers as well as campaigns. Our main goals are to increase EMEUNET’s visibility and distribute relevant content to all rheumatologists and researchers in Rheumatology across the world. We also have a specific role in being the “voice” of Annals of Rheumatic Diseases (ARD) on social media platforms, by closely collaborating with the ARD Team of the British Medical Journal (BMJ) to enhance the profile and activity of the Journal on these platforms.
We are responsible for managing and updating the content of all Social Media Platforms: website, Facebook page, Twitter, LinkedIn and YouTube channel. You can find all the up to date information on the website and easily connect with other members with similar areas of interest. Facebook and Twitter are readily accessible platforms, very intuitive, where you can follow all ongoing activities, deadlines and projects as they take place! This is why we encourage all our members and also non-members to join and support these initiatives.
Our aims include reaching out to as many young rheumatologists as possible and through our EMEUNET Country Liaisons and rheumatologists/scientists within their respective countries to use Twitter and Facebook for sharing information from national, international conferences and other meetings of interest. Our ultimate goal is to support EMEUNET in its initiative to keep every young rheumatologist in the world informed and involved in educational, clinical and research activities. Through our collaboration with ARD/BMJ, we hope to promote high quality clinical and research material and engagement of the wider rheumatology community on social media platforms.
If you have any information you think might be interesting for us to publish, please don’t hesitate to contact us on any of the platforms or by email (email@example.com). Furthermore, we are always happy to receive any comments/suggestions you may have!
What our Social Media Platforms offer you:
- Up to date information on what’s going on:
On our website, Twitter and Facebook page you will find announcements of interesting conferences, useful courses or exchange programs. We will update you with all important information such as registration links, schedules or travel bursaries and job opportunities. Our website is especially designed to meetthe needs of young rheumatologists/researchers in the field of rheumatology. It’s the only webpage collecting and gathering interesting information about rheumatology worldwide.
- Being an EMEUNET member - Connect – Interact – Access:
Once registered on our website, you become part of the EMEUNET network. You are included and have access to the EMEUNET Membership-database, where you can get in contact with other members, see their areas of interest, share information or initiate collaborations. Only EMEUNET members have full access to all our newsletters, and centers of excellence section.
- Provide important links & tools
The website provides important research links / clinical links for you, which should simplify your daily life as a rheumatologist or scientist. We have links to online tools, funding opportunities and all important Rheumatology Journals. Our website further provides a vast overview of courses and different educational offers.